查找临床试验
已按「特应性皮炎」检索，对应国际通用词 atopic dermatitis
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 10:14，每 5 分钟自动同步Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
China
年龄 18 Years – 75 Years
Keymed Biosciences Co.Ltd
A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis
China
年龄 18 Years – 不限
Jiangsu vcare pharmaceutical technology co., LTD
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
United States、China、Germany、Hungary、Japan 等 8 国
年龄 2 Years – 11 Years
Pfizer
A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients
China
年龄 18 Years – 75 Years
Shanghai Qilu Pharmaceutical Research and Development Center LTD
A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic Dermatitis
China
年龄 18 Years – 65 Years
ChinaNorm
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
China
年龄 18 Years – 75 Years
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
United States、Argentina、Canada、China、Czechia 等 12 国
年龄 18 Years – 100 Years
Novartis Pharmaceuticals
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
United States、Canada、China、France、Italy 等 9 国
年龄 12 Years – 不限
Sanofi
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
China
年龄 18 Years – 不限
Zhongda Hospital
A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection
China
年龄 18 Years – 55 Years
Jiangsu Genscend Biopharmaceutical Co., Ltd
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
China
年龄 不限 – 不限
Peking University First Hospital
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
United States、Australia、Canada、China、Germany 等 7 国
年龄 18 Years – 不限
Pfizer